Femtosecond infrared laser -: An efficient and safe in vivo gene delivery system for prolonged expression

被引:88
作者
Zeira, E
Manevitch, A
Khatchatouriants, A
Pappo, O
Hyam, E
Darash-Yahana, M
Tavor, E
Honigman, A
Lewis, A
Galun, E
机构
[1] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Ophthalmol, Hadassah Laser Ctr, IL-91120 Jerusalem, Israel
[3] Hadassah Univ Hosp, Dept Pathol, IL-91120 Jerusalem, Israel
[4] Hadassah Univ Hosp, Dept Hematol, IL-91120 Jerusalem, Israel
[5] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Virol, IL-91120 Jerusalem, Israel
关键词
gene therapy; naked DNA; gene expression in vivo; electroporation; nonviral vectors;
D O I
10.1016/S1525-0016(03)00184-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The major advantages of "naked DNA gene therapy" are its simplicity and a low or negligible immune response. Gene delivery by DNA electroporation (EP) involves injection of DNA and the application of a brief electric pulse to enhance cellular permeability. Although EP is an efficient gene transduction technique in rodents, it requires much higher voltages (>500 V) in larger animals, and hence, in practice it would be hazardous for human patients, as it would cause serious tissue damage. To overcome the obstacles associated with EP-mediated gene delivery in vivo, we developed a new method of gene transduction that uses laser energy. The femtosecond infrared titanium sapphire laser beam was developed specifically for enhancing in vivo gene delivery without risks of tissue damage. System optimization revealed that injection of 10 mug naked DNA into the tibial muscle of mice followed by application of the laser beam for 5 s, focused to 2 mm depth upon an area of 95 x 95 mum(2), resulted in the highest intensity and duration of gene expression with no histological or biochemical evidence of muscle damage. We assessed the potential clinical application of LBGT technology by using it to transfer the murine erythropoietin (mEpo) gene into mice. LBGT-mediated mEpo gene delivery resulted in elevated (>22%) hematocrit levels that were sustained for 8 weeks. Gene expression following LBGT was detected for >100 days. Hence, LBGT is a simple, safe, effective, and reproducible method for therapeutic gene delivery with significant clinical potential.
引用
收藏
页码:342 / 350
页数:9
相关论文
共 30 条
[11]   Gene therapy: Safer and virus-free? [J].
Ferber, D .
SCIENCE, 2001, 294 (5547) :1638-1642
[12]   Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy [J].
Hacein-Bey-Abina, S ;
Le Deist, F ;
Carlier, F ;
Bouneaud, C ;
Hue, C ;
De Villartay, JP ;
Thrasher, AJ ;
Wulffraat, N ;
Sorensen, R ;
Dupuis-Girod, S ;
Fischer, A ;
Cavazzana-Calvo, M ;
Davies, EG ;
Kuis, W ;
Lundlaan, WHK ;
Leiva, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (16) :1185-1193
[13]   Imaging transgene expression in live animals [J].
Honigman, A ;
Zeira, E ;
Ohana, P ;
Abramovitz, R ;
Tavor, E ;
Bar, I ;
Zilberman, Y ;
Rabinovsky, R ;
Gazit, D ;
Joseph, A ;
Panet, A ;
Shai, E ;
Palmon, A ;
Laster, M ;
Galun, E .
MOLECULAR THERAPY, 2001, 4 (03) :239-249
[14]   High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation [J].
Lavon, I ;
Goldberg, I ;
Amit, S ;
Landsman, L ;
Jung, S ;
Tsuberi, BZ ;
Barshack, I ;
Kopolovic, J ;
Galun, E ;
Bujard, H ;
Ben-Neriah, Y .
NATURE MEDICINE, 2000, 6 (05) :573-577
[15]   A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer [J].
Lefesvre, P ;
Attema, J ;
van Bekkum, D .
BMC MOLECULAR BIOLOGY, 2002, 3
[16]   Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells [J].
Lewin, M ;
Carlesso, N ;
Tung, CH ;
Tang, XW ;
Cory, D ;
Scadden, DT ;
Weissleder, R .
NATURE BIOTECHNOLOGY, 2000, 18 (04) :410-414
[17]   Synthetic DNA delivery systems [J].
Luo, D ;
Saltzman, WM .
NATURE BIOTECHNOLOGY, 2000, 18 (01) :33-37
[18]   Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery [J].
Mikszta, JA ;
Alarcon, JB ;
Brittingham, JM ;
Sutter, DE ;
Pettis, RJ ;
Harvey, NG .
NATURE MEDICINE, 2002, 8 (04) :415-419
[19]   Nucleic-acid therapeutics: Basic principles and recent applications [J].
Opalinska, JB ;
Gewirtz, AM .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :503-514
[20]   Stable nonviral genetic correction of inherited human skin disease [J].
Ortiz-Urda, S ;
Thyagarajan, B ;
Keene, DR ;
Lin, Q ;
Fang, M ;
Calos, MP ;
Khavari, PA .
NATURE MEDICINE, 2002, 8 (10) :1166-1170